Literature DB >> 30220531

Dynamics of the HIV outbreak and response in Scott County, IN, USA, 2011-15: a modelling study.

Gregg S Gonsalves1, Forrest W Crawford2.   

Abstract

BACKGROUND: In November, 2014, a cluster of HIV infections was detected among people who inject drugs in Scott County, IN, USA, with 215 HIV infections eventually attributed to the outbreak. This study examines whether earlier implementation of a public health response could have reduced the scale of the outbreak.
METHODS: In this modelling study, we derived weekly case data from the HIV outbreak in Scott County, IN, and on the uptake of HIV testing, treatment, and prevention services from publicly available reports from the US Centers for Disease Control and Prevention (CDC) and researchers from Indiana. Our primary objective was to determine if an earlier response to the outbreak could have had an effect on the number of people infected. We computed upper and lower bounds for cumulative HIV incidence by digitally extracting data from published images from a CDC study using Bio-Rad avidity incidence testing to estimate the recency of each transmission event. We constructed a generalisation of the susceptible-infectious-removed model to capture the transmission dynamics of the HIV outbreak. We computed non-parametric interval estimates of the number of individuals with an undiagnosed HIV infection, the case-finding rate per undiagnosed HIV infection, and model-based bounds for the HIV transmission rate throughout the epidemic. We used these models to assess the potential effect if the same intervention had begun at two key timepoints earlier than the actual date of the initiation of efforts to control the outbreak.
FINDINGS: The upper bound for undiagnosed HIV infections in Scott County peaked at 126 around Jan 10, 2015, over 2 months before the Governor of Indiana declared a public health emergency on March 26, 2015. Applying the observed case-finding rate scale-up to earlier intervention times suggests that an earlier public health response could have substantially reduced the total number of HIV infections (estimated to have been 183-184 infections by Aug 11, 2015). Initiation of a response on Jan 1, 2013, could have suppressed the number of infections to 56 or fewer, averting at least 127 infections; whereas an intervention on April 1, 2011, could have reduced the number of infections to ten or fewer, averting at least 173 infections.
INTERPRETATION: Early and robust surveillance efforts and case finding alone could reduce nascent epidemics. Ensuring access to HIV services and harm-reduction interventions could further reduce the likelihood of outbreaks, and substantially mitigate their severity and scope. FUNDING: US National Institute on Drug Abuse, US National Institutes of Mental Health, US National Institutes of Health Big Data to Knowledge programme, and the US National Institutes of Health.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30220531      PMCID: PMC6192548          DOI: 10.1016/S2352-3018(18)30176-0

Source DB:  PubMed          Journal:  Lancet HIV        ISSN: 2352-3018            Impact factor:   12.767


  15 in total

Review 1.  Association between knowledge of HIV-positive status or use of antiretroviral therapy and high-risk transmission behaviors: systematic review.

Authors:  Bernadette Zakher; Ian Blazina; Roger Chou
Journal:  AIDS Care       Date:  2013-09-05

2.  Ideological Anachronism Involving Needle and Syringe Exchange Programs: Lessons From the Indiana HIV Outbreak.

Authors:  Josiah D Rich; Eli Y Adashi
Journal:  JAMA       Date:  2015-07-07       Impact factor: 56.272

3.  Threading the Needle--How to Stop the HIV Outbreak in Rural Indiana.

Authors:  Steffanie A Strathdee; Chris Beyrer
Journal:  N Engl J Med       Date:  2015-06-24       Impact factor: 91.245

4.  Reduction of Injection-Related Risk Behaviors After Emergency Implementation of a Syringe Services Program During an HIV Outbreak.

Authors:  Monita R Patel; Carrie Foote; Joan Duwve; Erika Chapman; Brittany Combs; Alexandra Fry; Patti Hall; Jeremy Roseberry; John T Brooks; Dita Broz
Journal:  J Acquir Immune Defic Syndr       Date:  2018-04-01       Impact factor: 3.731

5.  Prevention of HIV-1 infection with early antiretroviral therapy.

Authors:  Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming
Journal:  N Engl J Med       Date:  2011-07-18       Impact factor: 91.245

6.  Providing ART to HIV Seropositive Persons Who Use Drugs: Progress in New York City, Prospects for "Ending the Epidemic".

Authors:  Don C Des Jarlais; Kamyar Arasteh; Courtney McKnight; Jonathan Feelemyer; Holly Hagan; Hannah L F Cooper; Aimee N C Campbell; Susan Tross; David C Perlman
Journal:  AIDS Behav       Date:  2016-02

7.  HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014-2015.

Authors:  Philip J Peters; Pamela Pontones; Karen W Hoover; Monita R Patel; Romeo R Galang; Jessica Shields; Sara J Blosser; Michael W Spiller; Brittany Combs; William M Switzer; Caitlin Conrad; Jessica Gentry; Yury Khudyakov; Dorothy Waterhouse; S Michele Owen; Erika Chapman; Jeremy C Roseberry; Veronica McCants; Paul J Weidle; Dita Broz; Taraz Samandari; Jonathan Mermin; Jennifer Walthall; John T Brooks; Joan M Duwve
Journal:  N Engl J Med       Date:  2016-07-21       Impact factor: 91.245

Review 8.  Mathematical models to characterize early epidemic growth: A review.

Authors:  Gerardo Chowell; Lisa Sattenspiel; Shweta Bansal; Cécile Viboud
Journal:  Phys Life Rev       Date:  2016-07-11       Impact factor: 11.025

Review 9.  Moving towards a reliable HIV incidence test - current status, resources available, future directions and challenges ahead.

Authors:  G Murphy; C D Pilcher; S M Keating; R Kassanjee; S N Facente; A Welte; E Grebe; K Marson; M P Busch; P Dailey; N Parkin; J Osborn; S Ongarello; K Marsh; J M Garcia-Calleja
Journal:  Epidemiol Infect       Date:  2016-12-22       Impact factor: 4.434

Review 10.  Effectiveness of needle and syringe Programmes in people who inject drugs - An overview of systematic reviews.

Authors:  Ricardo M Fernandes; Maria Cary; Gonçalo Duarte; Gonçalo Jesus; Joana Alarcão; Carla Torre; Suzete Costa; João Costa; António Vaz Carneiro
Journal:  BMC Public Health       Date:  2017-04-11       Impact factor: 3.295

View more
  31 in total

1.  Prevalent Misconceptions About Opioid Use Disorders in the United States Produce Failed Policy and Public Health Responses.

Authors:  Robert Heimer; Kathryn Hawk; Sten H Vermund
Journal:  Clin Infect Dis       Date:  2019-07-18       Impact factor: 9.079

2.  Making the Case for Syringe Services Programs.

Authors:  Jerome M Adams
Journal:  Public Health Rep       Date:  2020 Jul/Aug       Impact factor: 2.792

3.  Social norms associated with nonmedical opioid use in rural communities: a systematic review.

Authors:  Rebecca Bolinski; Kaitlin Ellis; Whitney E Zahnd; Suzan Walters; Colleen McLuckie; John Schneider; Christofer Rodriguez; Jerel Ezell; Samuel R Friedman; Mai Pho; Wiley D Jenkins
Journal:  Transl Behav Med       Date:  2019-11-25       Impact factor: 3.046

4.  Implementation of Syringe Services Programs to Prevent Rapid Human Immunodeficiency Virus Transmission in Rural Counties in the United States: A Modeling Study.

Authors:  William C Goedel; Maximilian R F King; Mark N Lurie; Sandro Galea; Jeffrey P Townsend; Alison P Galvani; Samuel R Friedman; Brandon D L Marshall
Journal:  Clin Infect Dis       Date:  2020-03-03       Impact factor: 9.079

5.  The Relationship Between Polysubstance Injection Drug Use, HIV Risk Behaviors, and Interest in Pre-Exposure Prophylaxis (PrEP) Among People Who Inject Drugs in Rural West Virginia.

Authors:  Kristin E Schneider; Rebecca Hamilton White; Rashelle J Musci; Allison O'Rourke; Michael E Kilkenny; Susan G Sherman; Sean T Allen
Journal:  J Stud Alcohol Drugs       Date:  2020-11       Impact factor: 2.582

6.  Factors Associated with Exchange Sex Among Cisgender Persons Who Inject Drugs: Women and MSM-23 U.S. Cities, 2018.

Authors:  Julie Rushmore; Kate Buchacz; Dita Broz; Christine B Agnew-Brune; Michelle L Johnson Jones; Susan Cha
Journal:  AIDS Behav       Date:  2022-06-25

7.  HIV Pre-exposure Prophylaxis for People Who Inject Drugs: The Context of Co-occurring Injection- and Sexual-Related HIV Risk in the U.S. Northeast.

Authors:  Alberto Edeza; Angela Bazzi; Peter Salhaney; Dea Biancarelli; Ellen Childs; Matthew J Mimiaga; Mari-Lynn Drainoni; Katie Biello
Journal:  Subst Use Misuse       Date:  2019-10-09       Impact factor: 2.164

8.  Longitudinal typing of molecular HIV clusters in a statewide epidemic.

Authors:  Vlad Novitsky; Jon Steingrimsson; Mark Howison; Casey Dunn; Fizza S Gillani; Akarsh Manne; Yuanning Li; Matthew Spence; Zoanne Parillo; John Fulton; Theodore Marak; Philip Chan; Thomas Bertrand; Utpala Bandy; Nicole Alexander-Scott; Joseph Hogan; Rami Kantor
Journal:  AIDS       Date:  2021-09-01       Impact factor: 4.632

9.  Principles of Harm Reduction for Young People Who Use Drugs.

Authors:  Simeon D Kimmel; Jessie M Gaeta; Scott E Hadland; Eliza Hallett; Brandon D L Marshall
Journal:  Pediatrics       Date:  2021-01       Impact factor: 7.124

10.  Are spatial models advantageous for predicting county-level HIV epidemiology across the United States?

Authors:  Danielle Sass; Bita Fayaz Farkhad; Bo Li; Man-Pui Sally Chan; Dolores Albarracín
Journal:  Spat Spatiotemporal Epidemiol       Date:  2021-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.